Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

Clinical trial NCT02055781 · TERMINATED

Trial details

NCT number: NCT02055781
Sponsor: CTI BioPharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2014-02-01
Primary completion: 2016-04-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.